Indore-based Modern Lab to manufacture Black Fungus drug Amphotericin B

The Madhya Pradesh government has given permission to the Indore-based Modern Laboratories to manufacture Amphotericin B drug used in the treatment of Black Fungus, White Fungus, and Yellow Fungus

coronavirus, vaccine, vaccination, covid-19
Representative image
ANI General News
1 min read Last Updated : May 31 2021 | 6:30 AM IST

The Madhya Pradesh government has given permission to the Indore-based Modern Laboratories to manufacture Amphotericin B drug used in the treatment of Black Fungus, White Fungus, and Yellow Fungus.

"The government gave the permission within 72 hours. Now, we will start production and start supplying injections in the market in 15 days," said Anil Kharia, Chairman, Modern Laboratories on Sunday.

"We will work with a capacity of manufacturing 10,000 injections daily and our priority will be to give them first to Madhya Pradesh and then to other states. This injection will be in the emulsion form. The price in the market will be around Rs 3,000, while we will give the government around Rs 1,500," he said.

Currently, Modern Lab is manufacturing Posaconazole medicine as an alternative to Amphotericin B.

Worth mentioning, there is a shortage of Liposomal Amphotericin B injections used in the treatment of diseases such as Black Fungus. About five such injections are given to each patient daily depending on their illness and body weight, the total number of which ranges from 50 to 80 injections.

The death toll from the disease in Indore is also on the rise due to the shortage.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus TestsIndorepharmaceutical firms

First Published: May 31 2021 | 6:28 AM IST

Next Story